UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Enzon Pharmaceuticals, Inc
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
293904108
--------------------------------------------------------------------------------
(CUSIP Number)
Jeffrey M. Elliott
Executive Vice President
Iridian Asset Management LLC
276 Post Road West
Westport, CT 06880-4704
203-341-9009
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 12, 2011
--------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 293904108 Schedule 13D Page 2
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Iridian Asset Management LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 5,842,257
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
5,842,257
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,842,257
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 3
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
COLE Partners LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 299,650
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
299,650
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
299,650
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.6%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
HC
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 4
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Iridian Private Business Value Equity Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 207,640
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
207,640
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
207,640
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.4%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 5
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Iridian Partners Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 92,010
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
92,010
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
92,010
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 6
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Renoma Partners LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 24,840
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,840
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,840
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
less than 0.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 7
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Iridian Charter Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 24,840
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
24,840
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
24,840
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
less than 0.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 8
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Harold J. Levy
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PN, OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 166,535
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 5,842,257
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 166,535
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
5,842,257
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,008,792
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 9
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
David L. Cohen
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 0
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 5,842,257
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
5,842,257
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,842,257
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
CUSIP No. 293904108 Schedule 13D Page 10
Item 1. Security and Issuer
This Schedule 13D, Amendment No. 4 relates to the common stock, par value $.01
per share (the "Common Stock"), of Enzon Pharmaceuticals, Inc., a Delaware
corporation (the "Issuer").
Issuer's princpial executive offices are located at 20 Kingsbridge Road,
Piscataway, NJ 08854.
The information presented on the cover sheets for each filing person is based
upon ownership as of August 12, 2011. The percent of class is based upon
48,688,085 shares of Common Stock issued and outstanding as of August 1, 2011 as
reported by the Issuer on its Form 10-Q for the period ended June 30, 2011.
This Amendment amends Item 5 of Schedule 13D previously filed as of Jan. 27, 2011. This Amendment reports a greater than 1% change in beneficial ownership by the
Reporting Persons as a resukt of the increase in the issued and outstanding shares of
the Issuer.
Item 5. Interest in Securities of the Issuer. (a), (b) As of August 10, 2011, the Reporting Persons may be deemed to beneficially own in the aggregate 5,842,257 shares of Common Stock, representing 11.8% of the outstanding Common Stock (the percentage of shares of Common Stock owned being based upon 48,688,085 shares of Common Stock outstanding at Aug. 1,
2011 as set forth in the Issuer's Quarterly Report on Form 10-Q for the period ended June 30, 2011). The Reporting Persons may be deemed to have direct beneficial ownership of shares of Common Stock as follows: Name Number of Shares Percentage Iridian (1) 5,517,767 11.3% Private Business 207,640 0.4% Partners 92,010 0.2% Charter 24,840 less than 0.01% Levy 166,535 0.3% (1) The shares of Common Stock set forth above for Iridian do not include the shares of Common Stock held by Private Business, Partners and Charter. Iridian has direct beneficial ownership of the shares of Common Stock in the accounts which it manages. In addition, Iridian is the investment adviser for Private Business, Partners and Charter. In such capacity, Iridian has the right
to vote and direct the disposition of shares of Common Stock held by such
entities and, consequently, has beneficial ownership of such shares. Messrs. Cohen and Levy may be deemed to possess beneficial ownership of the shares of Common Stock beneficially owned by Iridian by virtue of their indirect controlling ownership of Iridian, and having the power to vote and direct the disposition of shares of Common Stock as joint Chief Investment Officers of Iridian. Messrs. Cohen and Levy disclaim beneficial ownership of such shares. COLE, as the sole general partner of Private Business and Partners, may be deemed to own beneficially shares of Common Stock of which Private Business and Partners may be deemed to possess direct beneficial ownership. Iridian, as the sole member of COLE, may be deemed to possess beneficial ownership of the shares of Common Stock that are beneficially owned by COLE. Renoma, as the sole general partner of Charter, may be deemed to own beneficially shares of Common Stock of which Charter may be deemed to possess direct beneficial ownership. Iridian, as the sole member of Renoma, may be deemed to possess beneficial ownership of the shares of Common Stock that are beneficially owned by Renoma. Iridian has the direct power to vote or direct the vote, and the direct power to dispose or direct the disposition, of 5,842,257 shares of Common Stock. Messrs. Cohen and Levy may be deemed to share with Iridian the power to vote or direct the vote and to dispose or direct the disposition of such shares. Messrs. Cohen and Levy disclaim beneficial ownership of such shares. Iridian has the direct power to vote or direct the vote, and the direct power to dispose or direct the disposition, of the 207,640 shares of Common Stock held by Private Business and of the 92,010 shares of Common Stock held by Partners. COLE (in addition to Messrs. Cohen and Levy) may be deemed to share with Iridian the power to vote or direct the vote and to dispose or direct the disposition of such shares. Iridian has the direct power to vote or direct the vote, and the direct power to dispose or direct the disposition, of the 24,840 shares of Common Stock held by Charter. Renoma (in addition to Messrs. Cohen and Levy) may be deemed to share with Iridian the power to vote or direct the vote and to dispose or direct the disposition of such shares. Levy has the direct power to vote or direct the vote, and the direct power to dispose or direct the disposition, of the 166,535 shares of Common Stock held by him.
(c) Other than the transactions described in Schedule I of this statement, no
Reporting Person nor any director or executive officer of any Reporting Person
has effected any transactions in the Common Stock during the past 60 days.
(d) No person other than the Reporting Persons has any right to receive or the
power to direct the receipt of dividends from, or the proceeds of the sale of,
any of the Common Stock beneficially owned by the Reporting Persons, except that
the dividends from, or proceeds from the sale of, shares of Common Stock in each
respective account managed by Iridian will be delivered into each such
respective account.
(e) Not applicable.
SIGNATURE.
After reasonable inquiry and to the best of its or his knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.
Date: August 15, 2011
IRIDIAN ASSET MANAGEMENT LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
COLE PARTNERS LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
IRIDIAN PRIVATE BUSINESS VALUE EQUITY FUND, L.P.
By: COLE PARTNERS LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
IRIDIAN PARTNERS FUND, L.P.
By: COLE PARTNERS LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
RENOMA PARTNERS LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
IRIDIAN CHARTER FUND, LP
By: RENOMA PARTNERS LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Executive Vice President
David L. Cohen
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Agent
Harold J. Levy
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott, Agent
SCHEDULE I
REPORTING PERSONS TRANSACTIONS IN COMMON STOCK
|
Trade Date
|
Side
|
Number of Shares
|
Price Per Share (1)
|
|
6/13/2011
|
sell
|
60
|
$10.10
|
|
6/13/2011
|
sell
|
100
|
$10.10
|
|
6/13/2011
|
sell
|
100
|
$10.10
|
|
6/13/2011
|
sell
|
100
|
$10.10
|
|
6/13/2011
|
sell
|
200
|
$10.10
|
|
6/13/2011
|
sell
|
100
|
$10.10
|
|
6/13/2011
|
sell
|
10
|
$10.10
|
|
6/20/2011
|
sell
|
520
|
$10.07
|
|
6/20/2011
|
sell
|
200
|
$10.07
|
|
6/20/2011
|
sell
|
380
|
$10.07
|
|
6/20/2011
|
sell
|
220
|
$10.13
|
|
6/20/2011
|
sell
|
300
|
$10.13
|
|
6/20/2011
|
sell
|
2500
|
$10.13
|
|
6/20/2011
|
sell
|
100
|
$10.13
|
|
6/20/2011
|
sell
|
500
|
$10.13
|
|
6/20/2011
|
sell
|
700
|
$10.13
|
|
6/20/2011
|
sell
|
300
|
$10.13
|
|
6/20/2011
|
sell
|
1600
|
$10.13
|
|
6/20/2011
|
sell
|
1000
|
$10.13
|
|
6/20/2011
|
sell
|
300
|
$10.13
|
|
6/20/2011
|
sell
|
800
|
$10.13
|
|
6/20/2011
|
sell
|
1400
|
$10.13
|
|
6/20/2011
|
sell
|
700
|
$10.13
|
|
6/20/2011
|
sell
|
1100
|
$10.13
|
|
6/20/2011
|
sell
|
1700
|
$10.13
|
|
6/20/2011
|
sell
|
120
|
$10.13
|
|
6/24/2011
|
sell
|
760
|
$10.07
|
|
6/24/2011
|
sell
|
300
|
$10.07
|
|
6/24/2011
|
sell
|
100
|
$10.07
|
|
6/24/2011
|
sell
|
580
|
$10.07
|
|
6/24/2011
|
sell
|
230
|
$10.07
|
|
6/24/2011
|
sell
|
10
|
$10.07
|
|
6/24/2011
|
sell
|
270
|
$10.08
|
|
6/24/2011
|
sell
|
300
|
$10.08
|
|
6/24/2011
|
sell
|
1000
|
$10.08
|
|
6/24/2011
|
sell
|
100
|
$10.08
|
|
6/24/2011
|
sell
|
600
|
$10.08
|
|
6/24/2011
|
sell
|
100
|
$10.08
|
|
6/24/2011
|
sell
|
400
|
$10.08
|
|
6/24/2011
|
sell
|
200
|
$10.08
|
|
6/24/2011
|
sell
|
200
|
$10.08
|
|
6/24/2011
|
sell
|
300
|
$10.08
|
|
6/24/2011
|
sell
|
100
|
$10.08
|
|
6/24/2011
|
sell
|
100
|
$10.08
|
|
6/24/2011
|
sell
|
200
|
$10.08
|
|
6/24/2011
|
sell
|
200
|
$10.08
|
|
6/24/2011
|
sell
|
700
|
$10.08
|
|
6/24/2011
|
sell
|
180
|
$10.08
|
|
6/24/2011
|
sell
|
100
|
$10.08
|
|
6/24/2011
|
sell
|
160
|
$10.08
|
|
6/27/2011
|
sell
|
20
|
$10.23
|
|
6/27/2011
|
sell
|
90
|
$10.23
|
|
6/27/2011
|
sell
|
10
|
$10.23
|
|
6/27/2011
|
sell
|
10
|
$10.23
|
|
6/27/2011
|
sell
|
50
|
$10.23
|
|
6/27/2011
|
sell
|
200
|
$10.23
|
|
6/27/2011
|
sell
|
100
|
$10.23
|
|
6/27/2011
|
sell
|
200
|
$10.23
|
|
6/27/2011
|
sell
|
100
|
$10.23
|
|
6/27/2011
|
sell
|
10
|
$10.23
|
|
7/11/2011
|
sell
|
270
|
$10.23
|
|
7/18/2011
|
sell
|
30
|
$10.15
|
|
7/18/2011
|
sell
|
10
|
$10.15
|
|
7/18/2011
|
sell
|
20
|
$10.15
|
|
7/18/2011
|
sell
|
20
|
$10.15
|
|
7/18/2011
|
sell
|
20
|
$10.15
|
|
7/18/2011
|
sell
|
30
|
$10.15
|
|
7/18/2011
|
sell
|
50
|
$10.15
|
|
7/20/2011
|
sell
|
440
|
$10.20
|
|
7/20/2011
|
sell
|
1900
|
$10.20
|
|
7/20/2011
|
sell
|
900
|
$10.20
|
|
7/20/2011
|
sell
|
1500
|
$10.20
|
|
7/20/2011
|
sell
|
700
|
$10.20
|
|
7/20/2011
|
sell
|
2400
|
$10.20
|
|
7/20/2011
|
sell
|
200
|
$10.20
|
|
7/20/2011
|
sell
|
1400
|
$10.20
|
|
7/20/2011
|
sell
|
300
|
$10.20
|
|
7/20/2011
|
sell
|
650
|
$10.20
|
|
7/20/2011
|
sell
|
70
|
$10.19
|
|
7/21/2011
|
sell
|
520
|
$10.33
|
|
7/21/2011
|
sell
|
200
|
$10.33
|
|
7/21/2011
|
sell
|
1060
|
$10.33
|
|
7/22/2011
|
sell
|
110
|
$10.30
|
|
7/22/2011
|
sell
|
200
|
$10.30
|
|
7/22/2011
|
sell
|
20
|
$10.30
|
|
7/22/2011
|
sell
|
1060
|
$10.30
|
|
7/22/2011
|
sell
|
500
|
$10.30
|
|
7/22/2011
|
sell
|
500
|
$10.30
|
|
7/22/2011
|
sell
|
50
|
$10.30
|
|
7/25/2011
|
sell
|
890
|
$10.21
|
|
7/25/2011
|
sell
|
1500
|
$10.21
|
|
7/25/2011
|
sell
|
400
|
$10.21
|
|
7/25/2011
|
sell
|
100
|
$10.21
|
|
7/25/2011
|
sell
|
300
|
$10.21
|
|
7/25/2011
|
sell
|
500
|
$10.21
|
|
7/25/2011
|
sell
|
100
|
$10.21
|
|
7/25/2011
|
sell
|
820
|
$10.21
|
|
7/26/2011
|
sell
|
2350
|
$10.04
|
|
7/26/2011
|
sell
|
1900
|
$10.04
|
|
7/26/2011
|
sell
|
1720
|
$10.04
|
|
7/27/2011
|
sell
|
100
|
$9.91
|
|
7/27/2011
|
sell
|
260
|
$9.95
|
|
7/27/2011
|
sell
|
80
|
$9.95
|
|
7/27/2011
|
sell
|
10
|
$9.95
|
|
7/27/2011
|
sell
|
10
|
$9.95
|
|
8/1/2011
|
sell
|
360
|
$9.86
|
|
8/1/2011
|
sell
|
300
|
$9.86
|
|
8/1/2011
|
sell
|
600
|
$9.86
|
|
8/1/2011
|
sell
|
1200
|
$9.86
|
|
8/1/2011
|
sell
|
300
|
$9.86
|
|
8/1/2011
|
sell
|
1580
|
$9.86
|
|
(1) Price per share does not include commissions.
|
|||